The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Senescent cells develop a parp-1 and nuclear factor-κB-associated secretome (PNAS).
Open accessAbstract
Melanoma cells can enter the process of senescence, but whether they express a secretory phenotype, as reported for other cells, is undetermined. This is of paramount importance, because this secretome can alter the tumor microenvironment and the response to chemotherapeutic drugs. More generally, the molecular events involved in formation of the senescent-associated secretome have yet to be determined. We reveal here that melanoma cells experiencing senescence in response to diverse stimuli, including anti-melanoma drugs, produce an inflammatory secretory profile, where the chemokine ligand-2 (CCL2) acts as a critical effector. Thus, we reveal how senescence induction might be involved in therapeutic failure in melanoma. We further provide a molecular relationship between senescence induction and secretome formation by revealing that the poly(ADP-ribose) polymerase-1 (PARP-1)/nuclear factor-κB (NF-κB) signaling cascade, activated during senescence, drives the formation of a secretome endowed with protumoral and prometastatic properties. Our findings also point to the existence of the PARP-1 and NF-κB-associated secretome, termed the PNAS, in nonmelanoma cells. Most importantly, inhibition of PARP-1 or NF-κB prevents the proinvasive properties of the secretome. Collectively, identification of the PARP-1/NF-κB axis in secretome formation opens new avenues for therapeutic intervention against cancers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Blocking PARP-1, ATM, or NF-κB in melanoma cells prevents the secretion of chemokine CCL2 thereby restricting the deleterious pro-invasive properties of the inflammatory SASP mediated by PNAS (Ohanna et al., 2011).”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Ohanna et al., 2011
In the citing paper
“Chemotherapeutic drugs or oxidative stress induced DNA damage engage PARP-1/ATM/NF-κB signaling cascade to induce senescence in melanoma and non-melanoma cells (Ohanna et al., 2011).”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Ohanna et al., 2011
In the citing paper
“These senescent cells develop a PARP-1 and NF-κB associated secretome (PNAS) containing chemokine CCL2 along with other SASP factors thereby augmenting the invasiveness of melanoma cells which might have escaped senescence.”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Ohanna et al., 2011
In the citing paper
“some tumor cells can enter senescence in response to DNA damaging therapies [363,364].”
From Mechanisms and Regulation of Cellular Senescence (2021) · cites this paper as [364]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Ionizing radiation-induced NF-κB activation requires PARP-1 function to confer radioresistance
Veuger, S. J., Hunter, J. E., & Durkacz, B. W. (2008) · Oncogene · doi:10.1038/onc.2008.439 · Cited by 134
RetractedOncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218 · cited 1×
“Ordinarily, senescence is a process arising in normal cells in response to telomere erosion or oncogenic stress, acting through checkpoint activation and cell cycle arrest as a barrier to tumorigenesis (Serrano et al. 1997; Steinert et al. 2000).”
BackgroundThe senescence-associated secretory phenotype: the dark side of tumor suppression
Coppé, J.-P., Desprez, P.-Y., Krtolica, A., & Campisi, J. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102144 · Cited by 5,206
The Nuclear Factor NF- B Pathway in InflammationPreprint
Lawrence, T. (2009) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a001651 · Cited by 5,126
Hartwell, L. H., & Kastan, M. B. (1994) · Science · doi:10.1126/science.7997877 · Cited by 2,539
Oncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network
Kuilman, T., Michaloglou, C., Vredeveld, L. C. W., Douma, S., van Doorn, R., Desmet, C. J., Aarden, L. A., Mooi, W. J., & Peeper, D. S. (2008) · Cell · doi:10.1016/j.cell.2008.03.039 · Cited by 2,086
Cell Cycle Checkpoints: Preventing an Identity Crisis
Elledge, S. J. (1996) · Science · doi:10.1126/science.274.5293.1664 · Cited by 2,050
Chemokine signaling via the CXCR2 receptor reinforces senescence
Acosta, J. C., O'Loghlen, A., Banito, A., Guijarro, M. V., Augert, A., Raguz, S., Fumagalli, M., Da Costa, M., Brown, C., Popov, N., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.038 · Cited by 1,801 · cited 1×
“Some of these factors display cell-autonomous activity and work to reinforce the senescence program (Acosta et al. 2008; Kuilman et al. 2008).”
BackgroundKrtolica, A., Parrinello, S., Lockett, S., Desprez, P.-Y., & Campisi, J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.211053698 · Cited by 1,730
DNA repair pathways as targets for cancer therapy
Helleday, T., Petermann, E., Lundin, C., Hodgson, B., & Sharma, R. A. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2342 · Cited by 1,666
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–267 of 267
DNA damage remodels the MITF interactome to increase melanoma genomic instabilityPreprint
Binet, R., Lambert, J., Tomková, M., Tischfield, S., Baggiolini, A., Picaud, S., Sarkar, S., Louphrasitthiphol, P., Dias, D., Carreira, S., et al. (2024) · Genes & Development · doi:10.1101/gad.350740.123 · Cited by 10
Song, L., Leng, K., Xiao, K., & Zhang, S. (2022) · Fish Physiology and Biochemistry · doi:10.1007/s10695-022-01102-3 · Cited by 8
Microphthalmia-Associated Transcription Factor in Senescence and Age-Related Diseases
Zhang, J., Mou, Y., Gong, H., Chen, H., & Xiao, H. (2021) · Gerontology · doi:10.1159/000515525 · Cited by 8
Structure and biomedical applications of bioactive polyphenols from food and fruits
Chang, Y., He, F., Wang, T., & Aisa, H. A. (2022) · Journal of Food Processing and Preservation · doi:10.1111/jfpp.16789 · Cited by 9
Chen, P., Chang, C., Lin, W., Nagabhushanam, K., Ho, C., & Pan, M. (2022) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202101077 · Cited by 8
Zhu, N., Li, Y., & Xu, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052906 · Cited by 7
Bolden, J. E., & Lowe, S. W. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4066-6.00015-9 · Cited by 8
Walker, D. M., Nicklas, J. A., & Walker, V. E. (2013) · Environmental and Molecular Mutagenesis · doi:10.1002/em.21771 · Cited by 7
Leveraging PARP-1/2 to Target Distant Metastasis
Frederick, M. I., Abdesselam, D., Clouvel, A., Croteau, L., & Hassan, S. N. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25169032 · Cited by 6
Dietary restriction in senolysis and prevention and treatment of disease
Aminzadeh-Gohari, S., Kofler, B., & Herzog, C. M. S. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2153355 · Cited by 5
Inflammation and Oxidative DNA Damage
Martin, O. A., Nowsheen, S., Siva, S., Aziz, K., Hatzi, V. I., & Georgakilas, A. G. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-405205-5.00007-6 · Cited by 4
Mutant p53-Mediated Tumor Secretome: Bridging Tumor Cells and Stromal Cells
Qiu, L., Ma, Z., & Wu, X. (2024) · Genes · doi:10.3390/genes15121615 · Cited by 5
Metabolism under the spotlight in senescence
Bertolotto, C. (2013) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12184 · Cited by 3
Self-citationSevgin, B., Coban, M., Rencüzoğulları, Ö., Gürkan, A. Ç., Yerlikaya, P. O., Onganer, P. U., & Arısan, E. D. (2021) · Stresses · doi:10.3390/stresses1010005 · Cited by 4
Binet, R., Lambert, J., Tomková, M., Tischfield, S., Baggiolini, A., Picaud, S., Sarkar, S., Louphrasitthiphol, P., Dias, D., Carreira, S., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.04.21.537819 · Cited by 3
Decoding the tumor-aging axis: from bench to clinical
Wang, Y., Lv, G., Gao, X., Zheng, J. H., Huang, J., & Wang, Z. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1823423 · Cited by 2
Régulation épigénétique de l’expression génique dans le mélanome malin
Laurette, P., Koludrović, D., Coassolo, S., & Davidson, I. (2016) · Biologie Aujourd hui · doi:10.1051/jbio/2016028 · Cited by 2
Inflammation and oxidatively induced DNA damage: A synergy leading to cancer development
Tremi, I., Nowsheen, S., Aziz, K., Siva, S., Ventura, J. A., Hatzi, V. I., Martin, O. A., & Georgakilas, A. G. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819547-5.00013-4 · Cited by 2
Multitasking Roles for Poly(ADP-ribosyl)ation in Aging and Longevity
Mangerich, A., & Bürkle, A. (2015) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-3-319-14151-0_6 · Cited by 2
Regulatory Roles of PARP-1 and Lipids in Epigenetic Mechanisms
Mennella, M. R. F., Masi, A., & Ferreri, C. (2017) · Springer eBooks · doi:10.1007/978-3-319-31143-2_37-1 · Cited by 2
Murphy, C., Devis, L., Struck, R., Boloix, A., Gallagher, C., Gavin, C., Cottone, F., Soriano, A., Madden, S. F., Roma, J. M., et al. (2024) · PLoS ONE · doi:10.1371/journal.pone.0303643 · Cited by 2
Tricarico, R., Madžo, J., Scher, G., Maegawa, S., Jelı́nek, J., Scher, C., Chang, W., Nicolas, É., Zhou, Y., Slifker, M. J., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/676445 · Cited by 2
Gautron, A., Bachelot, L., Quéméner, A. M., Corre, S., Aubry, M., Rambow, F., Paris, A., Tardif, N., Leclair, H. M., Coulouarn, C., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.07.08.193102 · Cited by 2
Balancing senescence and apoptosis: therapeutic insights into aging and cancer
Jan, N., Sofi, S., Mir, A. A., Masoodi, G., & Mir, M. A. (2025) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-025-05355-3 · Cited by 1
Basak, S., Colafrancesco, A. M., Hernandez, R. D., Wei, X., McMeekin, L. J., Dang, D., Simmons, M., Browning, J. L., Noel, K., Zhou, F., et al. (2025) · Glia · doi:10.1002/glia.70112 · Cited by 1
Gong, T., Jiang, W., Han, Y., Liu, Y., Zhuo, W., Li, S., Hu, Z., Zeng, Z., Yue, R., & Yang, M. (2026) · Frontiers in Aging · doi:10.3389/fragi.2026.1779773 · Cited by 1
Cellular Senescence and the SASP in HFpEF: Pathogenic Mechanisms and Therapeutic Targeting
Zhu, Q., Zheng, Q., Zhang, H., Tu, Y., Wang, P., & Liu, X.-Z. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27125278 · Cited by 1
Altered Signal Transduction Pathways in Melanoma
Lau, E. K., & Ronai, Z. A. (2011) · Springer eBooks · doi:10.1007/978-3-7091-0371-5_7 · Cited by 1
Landscape and Targeting of the Angpt-Tie System in Current Anticancer Therapy
Sun, L., & Zhang, B. (2015) · Translational Medicine · doi:10.4172/2161-1025.1000157 · Cited by 1
Zelanis, A., Barcick, U., Racorti, N. D. V., & Salardani, M. D. S. (2023) · PROTEOMICS · doi:10.1002/pmic.202200243 · Cited by 1
zhang, M.-J., Xue, T.-T., Fei, X., Zhang, Y., Luo, Y., Ru, Y., Jiang, J., Song, J., Kuai, L., Luo, Y., et al. (2024) · Clinical & Experimental Immunology · doi:10.1093/cei/uxae052 · Cited by 1
Transition des cellules de mélanome vers un phénotype invasif et pharmacorésistant
Bertolotto, C., Ohanna, M., & Ballotti, R. (2018) · médecine/sciences · doi:10.1051/medsci/2018283 · Cited by 1
Self-citationRegulatory Roles of PARP-1 and Lipids in Epigenetic Mechanisms
Mennella, M. R. F., Masi, A., & Ferreri, C. (2019) · Springer eBooks · doi:10.1007/978-3-319-55530-0_37 · Cited by 1
Induction of cellular senescence as a novel therapeutic strategy for melanoma treatment
Zhang, G. (2012) · ScholarlyCommons (University of Pennsylvania)
Targeting the Prostate Cancer Microenvironment to Improve Therapeutic Outcomes
Sun, Y. (2013) · Defense Technical Information Center (DTIC) · doi:10.21236/ada585098
Is the Induction of Tumor Cell Senescence the Key to a Good Irradiated Tumor Vaccine?
Brown, M. P. (2012) · Molecular Therapy · doi:10.1038/mt.2012.72
Nidadavolu, L. S. (2013) · D-Scholarship@Pitt (University of Pittsburgh)
her2 hyper-activation through the production of carboxy-terminal fragments
Angelini, P. D. (2014) · TDX (Tesis Doctorals en Xarxa)
Cellular Senescence as a Novel Mechanism of Chronic Inflammation and Cancer Progression
Ohtani, N. (2016) · Springer eBooks · doi:10.1007/978-4-431-56068-5_15
Ageing Astrocytes - Implications for Motoneuron Dysfunction and Sarcopenia
Arpel, C. (2017) · Otago University Research Archive (University of Otago)
Role of Altered Extracellular Signalling in Cellular Senescence
Takasugi, M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.11427-8
Altered Signal Transduction Pathways in Melanoma
Chéli, Y., Lau, E. K., & Ronai, Z. A. (2017) · Springer eBooks · doi:10.1007/978-3-319-41319-8_7
Preclinical evaluation of senescence-based strategies to improve cancer therapy
Estepa‐Fernández, A. (2022) · RiuNet (Universitat Politècnica de València) · doi:10.4995/thesis/10251/188845
Borgonetti, V., Sasia, C., Morozzi, M., Cenci, L., & Galeotti, N. (2023) · Nutraceuticals · doi:10.3390/nutraceuticals3020020
Epigenetic Iinsights into the Senescence of Porcine Fetal Fibroblasts induced by Passaging
Bi, J., Wang, D., Zhu, F., Lu, X., Xie, Y., Liu, H., Wang, M., He, X., Jiang, Y. Z., Liu, P., et al. (2023) · Cell Cycle · doi:10.1080/15384101.2023.2222521
The molecular neural mechanism underlying the acceleration of brain aging due to Dcf1 deficiency
Zhou, H., Wang, J., & Wen, T. (2023) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2023.103884
Pierdoná, V., Lavandoski, P., Maurmann, R. M., Borges, G. A., Mombach, J. C. M., Guma, F. T. C. R., & Barbé‐Tuana, F. M. (2025) · Aging Medicine · doi:10.1002/agm2.70020
Additional file 5 of MITF induces escape from innate immunity in melanoma
Sánchez‐del‐Campo, L., Martí-Díaz, R., Montenegro, M. F., González-Guerrero, R., Hernández‐Caselles, T., Martínez‐Barba, E., Piñero, A., Cabezas‐Herrera, J., Goding, C. R., & López, J. N. R. (2021) · Figshare · doi:10.6084/m9.figshare.14355076
Additional file 2 of MITF induces escape from innate immunity in melanoma
Sánchez‐del‐Campo, L., Martí-Díaz, R., Montenegro, M. F., González-Guerrero, R., Hernández‐Caselles, T., Martínez‐Barba, E., Piñero, A., Cabezas‐Herrera, J., Goding, C. R., & López, J. N. R. (2021) · Figshare · doi:10.6084/m9.figshare.14355067
Additional file 3 of MITF induces escape from innate immunity in melanoma
Sánchez‐del‐Campo, L., Martí-Díaz, R., Montenegro, M. F., González-Guerrero, R., Hernández‐Caselles, T., Martínez‐Barba, E., Piñero, A., Cabezas‐Herrera, J., Goding, C. R., & López, J. N. R. (2021) · Figshare · doi:10.6084/m9.figshare.14355070
Additional file 1 of MITF induces escape from innate immunity in melanoma
Sánchez‐del‐Campo, L., Martí-Díaz, R., Montenegro, M. F., González-Guerrero, R., Hernández‐Caselles, T., Martínez‐Barba, E., Piñero, A., Cabezas‐Herrera, J., Goding, C. R., & López, J. N. R. (2021) · Figshare · doi:10.6084/m9.figshare.14355064
Additional file 4 of MITF induces escape from innate immunity in melanoma
Sánchez‐del‐Campo, L., Martí-Díaz, R., Montenegro, M. F., González-Guerrero, R., Hernández‐Caselles, T., Martínez‐Barba, E., Piñero, A., Cabezas‐Herrera, J., Goding, C. R., & López, J. N. R. (2021) · Figshare · doi:10.6084/m9.figshare.14355073
Additional file 6 of MITF induces escape from innate immunity in melanoma
Sánchez‐del‐Campo, L., Martí-Díaz, R., Montenegro, M. F., González-Guerrero, R., Hernández‐Caselles, T., Martínez‐Barba, E., Piñero, A., Cabezas‐Herrera, J., Goding, C. R., & López, J. N. R. (2021) · Figshare · doi:10.6084/m9.figshare.14355079
Additional file 7 of MITF induces escape from innate immunity in melanoma
Sánchez‐del‐Campo, L., Martí-Díaz, R., Montenegro, M. F., González-Guerrero, R., Hernández‐Caselles, T., Martínez‐Barba, E., Piñero-Madrona, A., Cabezas‐Herrera, J., Goding, C. R., & López, J. N. R. (2021) · Figshare · doi:10.6084/m9.figshare.14355082
Additional file 8 of MITF induces escape from innate immunity in melanoma
Sánchez‐del‐Campo, L., Martí-Díaz, R., Montenegro, M. F., González-Guerrero, R., Hernández‐Caselles, T., Martínez‐Barba, E., Piñero, A., Cabezas‐Herrera, J., Goding, C. R., & López, J. N. R. (2021) · Figshare · doi:10.6084/m9.figshare.14355085
Additional file 9 of MITF induces escape from innate immunity in melanoma
Sánchez‐del‐Campo, L., Martí-Díaz, R., Montenegro, M. F., González-Guerrero, R., Hernández‐Caselles, T., Martínez‐Barba, E., Piñero, A., Cabezas‐Herrera, J., Goding, C. R., & López, J. N. R. (2021) · Figshare · doi:10.6084/m9.figshare.14355088
Epigenetic regulation of gene expression during melanocyte and melanoma development
Laurette, P. (2016) · theses.fr (ABES) · doi:10.70675/b22b69c4z85a0z409czaccczc882ea46e923
de Freitas, J. A. N. L. F. (2020) · theses.fr (ABES) · doi:10.70675/0e6e3614z3915z4fb8za2cdz24b40b9679b2
Rôle de la kinase ARAF dans le mélanome cutané muté NRAS
Estrada, C. (2020) · theses.fr (ABES) · doi:10.70675/e84b4f6az1676z4c2dz80e4zd8668460d3c5
Dissecting the non-cell autonomous impact of cellular senescence on cellular reprogramming
von Joest, M. (2019) · theses.fr (ABES) · doi:10.70675/01382339z05d9z4aacz911dz62afcc7c9191
Identification et modulation des voies moléculaires impliquées dans l’agressivité du mélanome cutané
Gautron, A. (2019) · theses.fr (ABES) · doi:10.70675/b9c75939z7407z49abzafcbze6e92703d459
Étude et identification des états transcriptionnels dans le mélanome uvéal primaire
Pandiani, C. (2020) · theses.fr (ABES) · doi:10.70675/5d177eeaz698bz4c28z8015za4cfbbfd873d
Dissecting the impact of cellular senescence on muscle regeneration
Cazin, C. (2020) · theses.fr (ABES) · doi:10.70675/42a7ff38zb338z4eb8za925z2ce0a01ee74e
Reverse aging through cell cycle regulation
Sheoran, P., Tripathi, R. D., Mishra, S. K., Marathe, N. K., Yadav, A., Bhardwaj, A., Singh, P., Singh, K., Tikhonova, M. A., Gopenath, T. S., et al. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-33159-6.00014-x
Differentiation state affects PD-L1 expression in cutaneous melanoma: a systematic review
Sævarsson, T., Vu, H. N., Steingrı́msson, E., & Einarsdottir, B. O. (2026) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-026-00934-8
Metadata
- Authors
- Ohanna, M., Giuliano, S., Bonet, C., Imbert, V., Hofman, V., Zangari, J., Bille, K., Robert, C., Bressac-de Paillerets, B., Hofman, P., Rocchi, S., Peyron, J.-F., Lacour, J.-P., Ballotti, R., & Bertolotto, C.
- Affiliations
- Inserm (FR)
- Institut Gustave Roussy (FR)
- Centre Hospitalier Universitaire de Nice (FR)
- ORCID
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2011-06-06
- Volume
- 25
- Issue
- 12
- Pages
- 1245-1261
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- PMC
- PMC3127427
- OpenAlex
- W2162942873
- Cited by
- 267
- References
- 67
- Citations by year
- 2026: 6 · 2025: 9 · 2024: 17 · 2023: 24 · 2022: 20 · 2021: 33 · 2020: 25 · 2019: 15 · 2018: 16 · 2017: 13 · 2016: 16 · 2015: 17 · 2014: 13 · 2013: 21 · 2012: 15
- Type
- posted content
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Genes & Development (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Funders
- Association pour la Recherche sur le Cancer
- Institut National de la Santé et de la Recherche Médicale
- Fondation de France
- Institut National Du Cancer
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Keywords
- cellular senescence, senescence-associated secretome, melanoma, PARP1, NF-κB signaling, MCP-1, chemokines, tumor microenvironment, chemoresistance, metastasis, tumor invasion
- MeSH terms
- Poly (ADP-Ribose) Polymerase-1, DNA Damage, Humans, Melanoma, Neoplasm Invasiveness, Poly(ADP-ribose) Polymerases, Signal Transduction, Gene Expression Regulation, Neoplastic, NF-kappa B, Cellular Senescence, Chemokine CCL2, Gene Expression Profiling, Cell Line, Tumor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
